share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hassan Fred

SEC ·  Sep 6 04:08
Summary by Futu AI
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Hassan Fred, a person associated with the company. The transaction took place on September 3, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved and the transaction price, have not been disclosed. The relationship of Hassan Fred to the issuer was not specified in the announcement. Investors are advised to seek additional information to fully understand the impact of this transaction on their investment decisions.
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Hassan Fred, a person associated with the company. The transaction took place on September 3, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved and the transaction price, have not been disclosed. The relationship of Hassan Fred to the issuer was not specified in the announcement. Investors are advised to seek additional information to fully understand the impact of this transaction on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated